<p>Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts</p>Ashenafi Bulle, Jos van Pelt|OncoTargets and Therapy|2020Cited by 16
Abstract A081: Resistance Mechanisms to Monotherapy RAS(ON) Multi-Selective Inhibitor Daraxonrasib (RMC-6236) in RAS Mutant PDAC Inform Therapeutic Combination StrategiesIda Aronchik, Mallika Singh, Lo Lai et al.|Molecular Cancer Therapeutics|2025Cited by 1